Some pharmaceutical makers showing brisk sales in first half

Published: 2004-08-16 07:00:00

Updated: 2004-08-16 07:00:00

Three leading pharmaceutical firms Kwangdong, Hanmi and Dong-A, saw their sales revenue surge in the first half of this year despite the lengthy slump for the domestic pharmaceutical industry.

The majority of local pharmaceutical firms marked an average growth rate of 10 percent in sales from...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK